D
Humana Inc. HUM
$305.08 -$0.82-0.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
D
Sell 4/1/2024Downgrade
Humana Inc. (HUM) was downgraded to D+ from C- on 4/1/2024 due to a noticeable decline in the total return index and volatility index.
C
Hold 2/16/2024Downgrade
Humana Inc. (HUM) was downgraded to C- from C on 2/16/2024 due to a large decline in the growth index, volatility index and solvency index. Operating cash flow declined 669.81% from $1.25B to -$7.13B, earnings per share declined from $6.71 to -$4.4177, and EBIT declined 95.6% from $1.27B to $56M.
C
Hold 1/26/2024Downgrade
Humana Inc. (HUM) was downgraded to C from C+ on 1/26/2024 due to a decline in the volatility index and total return index.
C
Hold 1/8/2024Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 1/8/2024 due to a decline in the total return index and volatility index.
B
Buy 11/20/2023Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 11/20/2023 due to an increase in the volatility index and valuation index.
C
Hold 11/3/2023Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 11/3/2023 due to a large decline in the growth index, efficiency index and valuation index. Operating cash flow declined 60.58% from $3.18B to $1.25B, EBIT declined 16.58% from $1.53B to $1.27B, and net income declined 13.24% from $959M to $832M.
B
Buy 10/24/2023Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 10/24/2023 due to an increase in the volatility index.
C
Hold 8/17/2023Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 8/17/2023 due to a significant decline in the growth index, efficiency index and volatility index. Operating cash flow declined 52.5% from $6.69B to $3.18B, net income declined 22.6% from $1.24B to $959M, and earnings per share declined from $9.87 to $7.66.
B
Buy 7/13/2023Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 7/13/2023 due to a noticeable decline in the volatility index, total return index and efficiency index.
B
Buy 4/27/2023Upgraded
Humana Inc. (HUM) was upgraded to B from B- on 4/27/2023 due to a significant increase in the growth index, solvency index and valuation index. Earnings per share increased from -$0.1194 to $9.87, EBIT increased 450.96% from $312M to $1.72B, and operating cash flow increased 230.43% from -$5.13B to $6.69B.
B
Buy 4/25/2023Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 4/25/2023 due to an increase in the volatility index.
C
Hold 4/10/2023Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 4/10/2023 due to a decline in the volatility index, valuation index and total return index.
B
Buy 3/13/2023Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 3/13/2023 due to an increase in the volatility index and valuation index.
C
Hold 2/17/2023Downgrade
Humana Inc. (HUM) was downgraded to C+ from B on 2/17/2023 due to a significant decline in the growth index, total return index and solvency index. Operating cash flow declined 160.65% from $8.45B to -$5.13B, earnings per share declined from $9.39 to -$0.1194, and EBIT declined 75.12% from $1.25B to $312M.
B
Buy 12/23/2022Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 12/23/2022 due to a decline in the total return index, valuation index and efficiency index. Total capital declined 5.5% from $28.73B to $27.15B.
B
Buy 11/1/2022Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 11/1/2022 due to a significant increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.87 to 0.85.
B
Buy 4/29/2022Upgraded
Humana Inc. (HUM) was upgraded to B from C+ on 4/29/2022 due to a significant increase in the growth index, total return index and efficiency index. Earnings per share increased from -$0.1089 to $7.29, net income increased 6,742.86% from -$14M to $930M, and EBIT increased 2,013.11% from $61M to $1.29B.
C
Hold 3/15/2022Upgraded
Humana Inc. (HUM) was upgraded to C+ from C on 3/15/2022 due to an increase in the volatility index and total return index.
C
Hold 2/23/2022Downgrade
Humana Inc. (HUM) was downgraded to C from B- on 2/23/2022 due to a significant decline in the growth index and solvency index. Operating cash flow declined 103.39% from $2.84B to -$96M, earnings per share declined from $11.84 to -$0.1089, and EBIT declined 96.53% from $1.76B to $61M.
B
Buy 11/8/2021Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 11/8/2021 due to a substantial increase in the growth index and valuation index. Operating cash flow increased 687.5% from $360M to $2.84B, earnings per share increased from $4.55 to $11.84, and EBIT increased 42.15% from $1.24B to $1.76B.
C
Hold 7/30/2021Downgrade
Humana Inc. (HUM) was downgraded to C+ from B on 7/30/2021 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 28.99% from $828M to $588M, earnings per share declined from $6.39 to $4.55, and total revenue declined 0.11% from $20.67B to $20.65B.
B
Buy 5/3/2021Upgraded
Humana Inc. (HUM) was upgraded to B from C on 5/3/2021 due to a significant increase in the growth index, solvency index and total return index. EBIT increased 488.25% from -$315M to $1.22B, earnings per share increased from -$2.0743 to $6.39, and total revenue increased 8.43% from $19.06B to $20.67B.
C
Hold 3/30/2021Downgrade
Humana Inc. (HUM) was downgraded to C from C+ on 3/30/2021 due to a decline in the volatility index and valuation index.
C
Hold 3/15/2021Upgraded
Humana Inc. (HUM) was upgraded to C+ from C on 3/15/2021 due to an increase in the volatility index.
C
Hold 2/19/2021Downgrade
Humana Inc. (HUM) was downgraded to C from B- on 2/19/2021 due to a significant decline in the growth index, total return index and solvency index. Earnings per share declined from $10.05 to -$2.0743, EBIT declined 117.58% from $1.79B to -$315M, and operating cash flow declined 84.41% from $1.82B to $283M.
B
Buy 9/8/2020Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 9/8/2020 due to a noticeable decline in the total return index and volatility index.
B
Buy 6/18/2020Upgraded
Humana Inc. (HUM) was upgraded to B from B- on 6/18/2020 due to a major increase in the total return index and valuation index.
B
Buy 5/20/2020Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 5/20/2020 due to a significant increase in the growth index.
C
Hold 5/1/2020Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 5/1/2020 due to a major decline in the growth index, valuation index and volatility index. Operating cash flow declined 7.42% from $512M to $474M, and earnings per share declined from $3.8438 to $3.56.
B
Buy 3/17/2020Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 3/17/2020 due to a decline in the total return index and volatility index.
B
Buy 2/25/2020Upgraded
Humana Inc. (HUM) was upgraded to B from B- on 2/25/2020 due to a major increase in the growth index, total return index and efficiency index. Total revenue increased 0.33% from $16.24B to $16.3B.
B
Buy 10/23/2019Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 10/23/2019 due to an increase in the total return index and volatility index.
C
Hold 10/8/2019Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 10/8/2019 due to a decline in the total return index.
B
Buy 9/20/2019Upgraded
Humana Inc. (HUM) was upgraded to B- from C+ on 9/20/2019 due to an increase in the total return index, volatility index and valuation index.
C
Hold 8/2/2019Upgraded
Humana Inc. (HUM) was upgraded to C+ from C on 8/2/2019 due to a noticeable increase in the valuation index, growth index and efficiency index. Earnings per share increased from $4.16 to $6.94, net income increased 66.08% from $566M to $940M, and operating cash flow increased 60.04% from $896M to $1.43B.
C
Hold 7/23/2019Downgrade
Humana Inc. (HUM) was downgraded to C from C+ on 7/23/2019 due to a decline in the valuation index and dividend index.
C
Hold 7/5/2019Upgraded
Humana Inc. (HUM) was upgraded to C+ from C on 7/5/2019 due to an increase in the total return index and volatility index.
C
Hold 6/11/2019Downgrade
Humana Inc. (HUM) was downgraded to C from C+ on 6/11/2019 due to a noticeable decline in the volatility index, total return index and growth index.
C
Hold 4/15/2019Downgrade
Humana Inc. (HUM) was downgraded to C+ from B- on 4/15/2019 due to a large decline in the volatility index and total return index.
B
Buy 1/3/2019Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 1/3/2019 due to a significant decline in the total return index and growth index. Operating cash flow declined 744% from -$125M to -$1.06B, and total revenue declined 0.37% from $14.26B to $14.21B.
B
Buy 8/3/2018Downgrade
Humana Inc. (HUM) was downgraded to B from A- on 8/3/2018 due to a significant decline in the growth index, valuation index and volatility index. Operating cash flow declined 103.39% from $3.69B to -$125M, earnings per share declined from $3.53 to $1.39, and total revenue declined 0.14% from $14.28B to $14.26B.
A
Buy 5/7/2018Upgraded
Humana Inc. (HUM) was upgraded to A- from B+ on 5/7/2018 due to a large increase in the growth index, total return index and solvency index. Operating cash flow increased 226.62% from -$2.91B to $3.69B, earnings per share increased from $1.2875 to $3.53, and EBIT increased 28.45% from $601M to $772M.
B
Buy 3/20/2018Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 3/20/2018 due to a noticeable increase in the valuation index, total return index and efficiency index.
B
Buy 2/1/2018Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 2/1/2018 due to a decline in the total return index, valuation index and volatility index.
B
Buy 1/17/2018Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 1/17/2018 due to an increase in the total return index.
B
Buy 1/2/2018Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 1/2/2018 due to a decline in the total return index and volatility index.
B
Buy 12/5/2017Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 12/5/2017 due to a noticeable increase in the total return index.
B
Buy 11/20/2017Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 11/20/2017 due to a major decline in the total return index and volatility index.
B
Buy 11/13/2017Downgrade
Humana Inc. (HUM) was downgraded to B+ from A- on 11/13/2017 due to a decline in the growth index, total return index and solvency index. Earnings per share declined from $4.46 to $3.44, EBIT declined 10.73% from $1.1B to $982M, and total revenue declined 1.86% from $13.53B to $13.28B.
A
Buy 10/27/2017Upgraded
Humana Inc. (HUM) was upgraded to A- from B on 10/27/2017 due to a noticeable increase in the total return index and volatility index.
B
Buy 10/19/2017Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 10/19/2017 due to a decline in the total return index.
B
Buy 10/16/2017Downgrade
Humana Inc. (HUM) was downgraded to B+ from A- on 10/16/2017 due to a noticeable decline in the total return index and volatility index.
A
Buy 9/11/2017Upgraded
Humana Inc. (HUM) was upgraded to A- from B+ on 9/11/2017 due to an increase in the volatility index and total return index.
B
Buy 8/24/2017Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 8/24/2017 due to an increase in the volatility index and total return index.
B
Buy 8/4/2017Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 8/4/2017 due to a noticeable decline in the growth index and volatility index. Operating cash flow declined 102.52% from $4.21B to -$106M, earnings per share declined from $7.49 to $4.46, and total revenue declined 1.66% from $13.76B to $13.53B.
B
Buy 6/1/2017Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 6/1/2017 due to an increase in the total return index and volatility index.
B
Buy 5/10/2017Upgraded
Humana Inc. (HUM) was upgraded to B from C+ on 5/10/2017 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from -$2.6824 to $7.49, net income increased 378.05% from -$401M to $1.12B, and EBIT increased 290.6% from -$415M to $791M.
C
Hold 2/21/2017Downgrade
Humana Inc. (HUM) was downgraded to C+ from B on 2/21/2017 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $2.98 to -$2.6824, operating cash flow declined 161.58% from $4.5B to -$2.77B, and EBIT declined 142.83% from $969M to -$415M.
B
Buy 1/30/2017Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 1/30/2017 due to a decline in the volatility index and valuation index.
B
Buy 1/13/2017Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 1/13/2017 due to a significant increase in the total return index and volatility index.
B
Buy 11/7/2016Upgraded
Humana Inc. (HUM) was upgraded to B from B- on 11/7/2016 due to an increase in the volatility index, solvency index and valuation index. Debt to equity declined from 0.39 to 0.38.
B
Buy 6/13/2016Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 6/13/2016 due to a major decline in the total return index, valuation index and volatility index.
B
Buy 4/26/2016Upgraded
Humana Inc. (HUM) was upgraded to B from B- on 4/26/2016 due to a major increase in the total return index, valuation index and dividend index.
B
Buy 3/11/2016Downgrade
Humana Inc. (HUM) was downgraded to B- from B on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
B
Buy 2/19/2016Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 2/19/2016 due to a significant decline in the growth index, volatility index and valuation index. Earnings per share declined from $2.09 to $0.6631, operating cash flow declined 67.34% from $1.03B to $337M, and EBIT declined 58.42% from $695M to $289M.
B
Buy 1/25/2016Downgrade
Humana Inc. (HUM) was downgraded to B+ from A- on 1/25/2016 due to a major decline in the volatility index and solvency index.
A
Buy 11/6/2015Upgraded
Humana Inc. (HUM) was upgraded to A- from B+ on 11/6/2015 due to a significant increase in the growth index, volatility index and solvency index. EBIT increased 21.29% from $573M to $695M, debt to equity declined from 0.44 to 0.4, and the quick ratio increased from 1.27 to 1.29.
B
Buy 2/20/2015Upgraded
Humana Inc. (HUM) was upgraded to B+ from B on 2/20/2015 due to a major increase in the total return index, growth index and valuation index. Total revenue increased 0.74% from $12.24B to $12.33B.
B
Buy 11/10/2014Downgrade
Humana Inc. (HUM) was downgraded to B from B+ on 11/10/2014 due to a major decline in the total return index, valuation index and growth index. Operating cash flow declined 577% from -$200M to $954M, earnings per share declined from $2.19 to $1.85, and EBIT declined 13.51% from $681M to $589M.
B
Buy 8/1/2014Downgrade
Humana Inc. (HUM) was downgraded to B+ from A- on 8/1/2014 due to a substantial decline in the growth index, volatility index and total return index. Operating cash flow declined 129.81% from $671M to -$200M, earnings per share declined from $2.35 to $2.19, and EBIT declined 5.55% from $721M to $681M.
A
Buy 7/2/2014Downgrade
Humana Inc. (HUM) was downgraded to A- from A on 7/2/2014 due to a decline in the total return index, volatility index and valuation index.
A
Buy 6/17/2014Upgraded
Humana Inc. (HUM) was upgraded to A from A- on 6/17/2014 due to a large increase in the total return index, volatility index and solvency index.
A
Buy 5/9/2014Upgraded
Humana Inc. (HUM) was upgraded to A- from B+ on 5/9/2014 due to a major increase in the growth index, total return index and solvency index. Total revenue increased 14.97% from $10.19B to $11.71B, and debt to equity declined from 0.32 to 0.29.
Weiss Ratings